Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Rotterdam study assesses risk factors for dementia and AD

May 7, 1997

Preclinical studies with sodium channel blockers in traumatic brain injury

May 6, 1997

Transdermal N-0923 effective in Parkinson's disease

May 6, 1997

COX-2 inhibitor shows potential for preventing neuronal death

May 6, 1997

Neuromyalgic response to rhNGF described

May 6, 1997

Clinical efficacy of Myotrophin in ALS and postpolio syndrome

May 6, 1997

ABT-431 evaluated in Parkinson's patients

May 6, 1997

New ganciclovir derivative from Norsk Hydro for HSV infections

May 5, 1997

Agouron presents rhinovirus 3C protease inhibitor as promising clinical candidate

May 5, 1997

Potential HSV-2 vaccine described by Aviron

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...